|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/395 | |
| C07K 16/28 | |||
| A61P 35/00 |
| (11) | Patento numeris | 1765397 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 05754219.3 |
| Europos patento paraiškos padavimo data | 2005-05-25 | |
| (97) | Europos patento paraiškos paskelbimo data | 2007-03-28 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2012-10-24 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2005/018322 |
| Data | 2005-05-25 |
| (87) | Numeris | WO 2005/116077 |
| Data | 2005-12-08 |
| (30) | Numeris | Data | Šalis |
| 573896 P | 2004-05-25 | US |
| (72) |
PARRY, Graham, C., US
MAZAR, Andrew P., US
|
| (73) |
Tactic Pharma, LLC,
1007 Church Street, Suite 307, Evanston 60201,
US
|
| (54) | Inhibitory antibodies binding the complex of urokinase-type plasminogen activator (uPA) and its receptor (uPAR) |
| Inhibitory antibodies binding the complex of urokinase-type plasminogen activator (uPA) and its receptor (uPAR) |